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1. Introduction 
The contractile activity of vertebrate striated 
muscle appears to be regulated by the troponin- 
tropomyosin complex located in the thin filaments 
of the myofibril [l] . In the absence of calcium, 
troponin inhibits the interaction of actin and myosin. 
Calcium binding to troponin reverses this inhibition 
and allows actin and myosin to form the crossbridges 
which initiate muscular contraction. Troponin consists 
of three subunits: TN-T, a tropomyosin binding 
protein, TN-I, a protein which inhibits the acto- 
myosin ATPase, and TN-C which binds calcium [2]. 
While cardiac and skeletal muscle troponin are 
functionally similar, their three subunits differ in 
molecular weights, amino acid composition, and 
column elution patterns (2). Although much infor- 
mation is available on calcium binding to skeletal 
muscle troponin, little work has been done on cardiac 
troponin. Using skinned frog skeletal muscle fibers 
and mechanically disrupted rat ventricular muscle 
fibers, Kerrick and Donaldson [3] concluded that 
similar molecular mechanism were responsible for the 
Ca2+-activation of the two muscle types. This was in 
contrast to the work of Ebashi et al. [4] who found 
that both the binding constant and capacity of cardiac 
troponin (3.4 X 10’ M-l, 1 mol Ca2’/105 g protein) 
were lower than that of skeletal muscle troponin. 
Van Eerd has compared the amino acid sequences of 
cardiac and skeletal muscle purified TN-C [S] and 
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proposed that cardiac TN-C contains 3 calcium bind- 
ing sites rather than the 4 sites assigned for skeletal 
TN-C. In view of the obvious differences between 
skeletal and cardiac troponins and the disagreement 
between experimental determinations of their calcium 
binding parameters, a more detailed analysis using 
purified troponin-tropomyosin was undertaken. 
It had also been demonstrated that cyclic AMP- 
dependent protein kinase catalyzed the phosphory- 
lation of TN-I in purified cardiac troponin [6,7] and 
that phosphorylation of TN-I was correlated directly 
with the increased contractility of rat hearts perfused 
with epinephrine [8]. Presumably stimulation of 
cyclic AMP formation by epinephrine resulted in 
activation of cyclic AMP-dependent protein kinase. 
Rubio et al. [9] suggested that phosphorylation of 
TN-I in the cardiac native actomyosin complex by 
the cyclic AMP-dependent protein kinase resulted in 
an increase in the calcium sensitivity of the actomyosin 
ATPase activity. This alteration of the actomyosin 
calcium sensitivity could arise from changes in the 
calcium binding parameters of troponin which regulate 
the ATPase activity. The purpose of this investigation 
was to characterize calcium binding to the cardiac 
troponin-tropomyosin complex and to determine if 
phosphorylation of the TN-I subunit in this complex 
altered the calcium binding parameters. 
2. Experimental 
Troponin-tropomyosin was purified from beef 
heart [6]. In order to determine the stoichiometry 
of bound calcium in addition to measuring the 
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affinity constants, it was essential to purify the 
troponin-tropomyosin as a complex which contained 
stoichiometric amounts of protein subunits. Quanti- 
tation of Coomassie Blue staining on SDS-polyacryl- 
amide gels with corrections for differences in stain 
uptake by the individual purified protein components 
showed that one mole of each of the four proteins 
was present in the troponin-tropomyosin complex. 
Cardiac troponin-tropomyosin was phosphorylated 
by incubation withATP, Mg*’ and cyclic AMP-depen- 
dent protein kinase as described [6] with incorpora- 
tion of 1.2 f 0.06 moles of phosphate per mole of 
troponin-tropomyosin. The phosphate was incor- 
porated specifically in the TN-I subunit in separate 
experiments using [Y-~~P] ATP. Total protein-bound 
phosphate in troponin-tropomyosin was measured 
before and after the phosphorylation reaction 161. 
All solutions used for calcium binding were 
treated with Chelex-100 (Bio-Rad) to reduce con- 
taminating calcium, then stored in plastic-ware. Less 
than 1 PM residual calcium was measured fluoro- 
metrically in the buffers or protein solutions [lo] . 
Proteins were dialyzed overnight against 250 mM 
KCl, 10 mM MOPS, 2 mM EDTA, 15 mM 2-mercapto- 
ethanol, pH 7.0, then dialyzed against three changes 
of 100 vol. 250 mM KCl, 30 mM MOPS, 2 mM 
MgC12, pH 7.0. Calcium binding to troponin-tropo- 
myosin was measured by equilibrium dialysis with 
microcells [ 111 containing 20 ~1 of solution in each 
chamber. After mixing for 4 h, 15 ~1 was withdrawn 
from each chamber and the first 10 ~1 was discharged 
into a counting vial for measurements of radioactivity. 
No changes in protein concentration or protein-bound 
phosphate content were detected after dialysis. SDS- 
polyacrylamide gel electrophoresis indicated no signi- 
ficant proteolysis of troponin-tropomyosin after 4 h. 
3. Results and discussion 
A typical calcium binding curve for nonphos- 
phorylated cardiac troponin-tropomyosin is shown 
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Fig.1. Effect of calcium concentration on calcium binding to cardiac and skeletal muscle troponin-tropomyosin. The total 
WaC1 concentration was varied from 2 MM to 1 mM and aliquots were obtained after 4 h dialysis The free calcium concentra- 
tion wis computed from a program using the ionic equilibria equations and binding constants of Donaldson and Kerrick [ 121. 
The solid curves represent he best fit obtained by an iterative least squares procedure to the equation: 
Bound calcium = 
“i Ki [Ca”] 
1 + Ki [Ca”] 
The values obtained for the cardiac proteins (0) were K, = 4.31 ~~10~ M-l n, = 1.74 mol Ca*+ bound/m01 protein and K, = 
6.4 x 10” M-l, nz = 4.2 mol Ca*+ bound/m01 protein. The values obtained for skeletal-muscle troponin-tropomyosin (o) are 
K, = 4.80 X lo6 M-’ and n, = 4.37 mol Ca*+ bound/m01 protein. 
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Table 1 
Calcium-binding parameters of cardiac troponin-tropomyosin 
Troponin-Tropomyosin K, n1 
(M-’ X 10v6) (mole/mole) 
K, 4 
(M-’ X.10-‘) (mole/mole 
Nonphosphorylated (6) 3.88 f 0.27 1.76 + 0.26 5.9 f 1.80 4.15 f 0.73 
Phosphorylated (5) 4.16 f 0.55 1.60 f 0.13 5.4 + 1.68 4.22 ?r 0.75 
The values for K and n are averages ? S.E.M. The number of determinations is shown in paren- 
theses. The data from each experiment were analyzed for K and n values as described in fii.2. 
After incubation with cyclic AMP-dependent protein kinase 1.2 + 0.06 moles of phosphate/ 
mole of troponin-tropomyosin were incorporated. 
myosin. Analysis of these data by an iterative least 
squares procedure suggested the presence of a single 
class of binding sites for the skeletal muscle proteins 
with a maximum binding of 4 mol Ca*‘/mol protein. 
These results are essentially identical to the values 
reported for skeletal muscle troponin [ 131 in the 
presence of Mg’+. In contrast the cardiac proteins 
appear to have 2 classes of binding sites. Calcium 
binding parameters of cardiac troponin-tropomyosin 
are summariyed in table 1. The 2 classes of binding 
sites differed in their affinity constants by 3 orders 
of magnitude (Kr = 3.9 X lo6 M-l, K2 = 5.9 X 1 O3 
M-r). Approximately 2 moles of Ca*’ were bound 
per mole of troponin-tropomyosin by the high 
affinity sites. Thus at 10 PM Ca*+ cardiac regulatory 
proteins bind 2 moles of Ca*+ whereas skeletal muscle 
regulatory proteins bind 4 moles of Ca*+. These results 
demonstrate another difference between the regula- 
tory proteins from these two muscles. 
Since Ca*+ binding to cardiac troponin-tropomyosin 
has been proposed to involve negative cooperativity 
[ 141, these data were further analyzed by a Hill 
plot (fig.2). The plot did not show a single line with 
a slope of less than unity which would be expected 
for negative cooperativity. Instead the curve was 
characteristic of 2 independent binding sites [ 151 
with limiting slopes of 0.86 at each end. This value 
is slightly less than unity since the affinities for the 
I 0 , I 
Fig.2. Hill plot of the calcium binding data of cardiac troponin-tropomyosin from fig.1. The solid curve represents the calculated 
isotherm obtained from the Ki and ni values of fig. 1. 
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2 classes are not separated by more than 104. Also 
the slope in the middle of the curve is slightly greater 
than zero and reflects the fact that at these inter- 
mediate Ca*+ concentrations the amount bound is 
affected by the affinities for both classes of binding 
sites. The lack of negative cooperativity contrasts 
with the data of Reddy and Honig [ 141 and can 
probably be explained by the differences in Ca’+ 
concentrations used in the experiments. The Chelex 
method of binding is limited to Ca*+ concentrations 
from IO-90 PM whereas with the use of an EGTA- 
Ca*+ buffer system we were able to vary the free 
Ca*+ concentration from 0.004-I 000 FM. 
From the amino acid sequence of the TN-C sub- 
unit of bovine cardiac troponin, van Eerd [5] has 
postulated that 3 calcium binding sites are present. 
However Solar0 and Shiner [ 161 have estimated that 
only 2 calcium binding sites regulate cardiac acto- 
myosin ATPase activity with an apparent affinity of 
approximately 1 O6 M-' . Therefore the high affinity 
calcium binding sites (K, = 3.9 X IO6 M-l) in the 
troponin-tropomyosin complex which bind 2 moles 
of Ca*+ may regulate crossbridge formation. The im- 
portance of the low affinity sites which bind 4 moles 
of Ca*+ is not apparent at this time. Further work is 
obviously needed to identify the calcium-binding 
characteristics of the separated components of the 
troponin-tropomyosin complex. 
Phosphorylation of cardiac troponin-tropomyosin 
by cyclic AMP-dependent protein kinase had no 
effect on either the affinity or the amount of calcium 
bound to the protein (table 1). Since the amount of 
endogenous phosphate in troponin-tropomyosin 
varied among different preparations, and was present 
in both the TN-I and TN-T subunits [6], the effect 
of this difference in phosphate content on calcium 
binding was also investigated. For two preparations 
of troponin-tropomyosin which contained 0.30 
moles and 0.83 moles of phosphate per mole of 
protein respectively, the affinities and capacities of 
the protein for calcium were not significantly dif- 
ferent from the values presented in table 1. 
These results do not support the proposal [9] 
that phosphorylation of cardiac TN-I by cyclic AMP- 
dependent protein kinase would cause an increase in 
the calcium sensitivity of the cardiac actomyosin 
ATPase activity by increasing the affinity or capacity 
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for Ca*+ binding to troponin. Therefore a change in 
calcium-binding properties to cardiac troponin-tropo- 
myosin is probably not the primary mechanism by 
which cyclic AMP may increase cardiac contractility. 
Other biochemical mechanisms related to the cyclic 
AMP-dependent phosphorylation of cardiac troponin 
must be explored. 
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